Literature DB >> 10568720

Anabolic effects of insulin-like growth factor in combination with insulin-like growth factor binding protein-3 in severely burned adults.

M A Debroy1, S E Wolf, X J Zhang, D L Chinkes, A A Ferrando, R R Wolfe, D N Herndon.   

Abstract

BACKGROUND: The purpose of this study was to determine the anabolic effects of recombinant human insulin-like growth factor-I (rhIGF-1) complexed with its principal binding protein IGF-1 binding protein-3 (IGFBP-3) in severely burned adults.
METHODS: Ten burned adults were studied consecutively after receiving saline (pretreatment), then rhIGF-1/IGFBP-3 (treatment) for 5 days. Doses were 1, 2, and 4 mg/kg per day. Glucose, electrolytes, hormones, and leg muscle protein metabolism were determined. Nine other studies were performed on similarly injured adults at comparable times to the treatment studies to control for time effects.
RESULTS: Serum IGF-1 and IGFBP-3 levels increased with all doses, but no incremental increases were found. Leg protein balance improved with rhIGF-1/IGFBP-3, which was associated with an increase in muscle protein fractional synthetic rate. These effects were independent of time. All patients were euglycemic without electrolyte imbalances.
CONCLUSION: Net protein synthesis in the isolated leg of severely burned adults improved with rhIGF-1/IGFBP-3 without development of glucose abnormalities.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10568720     DOI: 10.1097/00005373-199911000-00015

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  24 in total

Review 1.  Metabolic actions of insulin-like growth factor-I in normal physiology and diabetes.

Authors:  David R Clemmons
Journal:  Endocrinol Metab Clin North Am       Date:  2012-06       Impact factor: 4.741

Review 2.  Can we protect the gut in critical illness? The role of growth factors and other novel approaches.

Authors:  Jessica A Dominguez; Craig M Coopersmith
Journal:  Crit Care Clin       Date:  2010-07       Impact factor: 3.598

3.  Determinants of skeletal muscle catabolism after severe burn.

Authors:  D W Hart; S E Wolf; D L Chinkes; D C Gore; R P Mlcak; R B Beauford; M K Obeng; S Lal; W F Gold; R R Wolfe; D N Herndon
Journal:  Ann Surg       Date:  2000-10       Impact factor: 12.969

Review 4.  Anabolic and anticatabolic agents used in burn care: What is known and what is yet to be learned.

Authors:  Eduardo I Gus; Shahriar Shahrokhi; Marc G Jeschke
Journal:  Burns       Date:  2019-12-15       Impact factor: 2.744

5.  Adult patients are more catabolic than children during acute phase after burn injury: a retrospective analysis on muscle protein kinetics.

Authors:  Demidmaa Tuvdendorj; David L Chinkes; Xiao-Jun Zhang; Arny A Ferrando; Itoro E Elijah; Ronald P Mlcak; Celeste C Finnerty; Robert R Wolfe; David N Herndon
Journal:  Intensive Care Med       Date:  2011-06-07       Impact factor: 17.440

Review 6.  What, how, and how much should patients with burns be fed?

Authors:  Felicia N Williams; Ludwik K Branski; Marc G Jeschke; David N Herndon
Journal:  Surg Clin North Am       Date:  2011-06       Impact factor: 2.741

7.  Open-label trial of recombinant human insulin-like growth factor 1/recombinant human insulin-like growth factor binding protein 3 in myotonic dystrophy type 1.

Authors:  Chad R Heatwole; Katy J Eichinger; Deborah I Friedman; James E Hilbert; Carlayne E Jackson; Eric L Logigian; William B Martens; Michael P McDermott; Shree K Pandya; Christine Quinn; Alexis M Smirnow; Charles A Thornton; Richard T Moxley
Journal:  Arch Neurol       Date:  2010-09-13

Review 8.  Insulin resistance postburn: underlying mechanisms and current therapeutic strategies.

Authors:  Gerd G Gauglitz; David N Herndon; Marc G Jeschke
Journal:  J Burn Care Res       Date:  2008 Sep-Oct       Impact factor: 1.845

9.  Pathophysiologic response to severe burn injury.

Authors:  Marc G Jeschke; David L Chinkes; Celeste C Finnerty; Gabriela Kulp; Oscar E Suman; William B Norbury; Ludwik K Branski; Gerd G Gauglitz; Ronald P Mlcak; David N Herndon
Journal:  Ann Surg       Date:  2008-09       Impact factor: 12.969

10.  Local insulin-like growth factor I prevents sepsis-induced muscle atrophy.

Authors:  Gerald Nystrom; Anne Pruznak; Danuta Huber; Robert A Frost; Charles H Lang
Journal:  Metabolism       Date:  2009-06       Impact factor: 8.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.